Tokyo, Japan

Uchiyama Masamori

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignees: Happy World Inc., Ilhwa Co., Ltd.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Uchiyama Masamori. Retrieved from https://idiyas.com/inventor/uchiyama-masamori

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Uchiyama Masamori: Innovator in Ginseng Research

Introduction

Uchiyama Masamori is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of biochemistry, particularly in the study of ginseng saponins. His work has implications for health and nutrition, showcasing the potential benefits of natural compounds.

Latest Patents

Uchiyama holds a patent for "Metabolites of ginseng saponins by human intestinal bacteria and its." This patent highlights his research into how ginseng saponins are processed in the human body, which could lead to advancements in dietary supplements and health products. He has 1 patent to his name.

Career Highlights

Throughout his career, Uchiyama has worked with various companies, including Ilhwa Co., Ltd. and Happy World Inc. His experience in these organizations has allowed him to apply his research in practical settings, contributing to the development of health-related products.

Collaborations

Uchiyama has collaborated with notable individuals in his field, including Hasegawa Hideo and Jong Hwan Sung. These partnerships have enriched his research and expanded the impact of his work.

Conclusion

Uchiyama Masamori's contributions to the study of ginseng saponins demonstrate the importance of innovation in health research. His patent and collaborations reflect a commitment to advancing our understanding of natural compounds and their benefits.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…